ResearcherTUM KlinikumNo recent work listed
Ana Hidalgo‐Sastre
Matched on OpenAlex author ID A5024777066. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 24
2016: 2 papers · 2017: none · 2018: none · 2019: 1 paper · 2020: 1 paper
Papers 4
- Loss of Wasl improves pancreatic cancer outcome. Co-author DOI 10.1172/jci.insight.127275↗
- MEK Inhibition Targets Cancer Stem Cells and Impedes Migration of Pancreatic Cancer Cells In Vitro and In Vivo. Co-author DOI 10.1155/2019/8475389↗
- Hes1 Controls Exocrine Cell Plasticity and Restricts Development of Pancreatic Ductal Adenocarcinoma in a Mouse Model. Co-author DOI 10.1016/j.ajpath.2016.07.025↗
- Membranous CD24 drives the epithelial phenotype of pancreatic cancer. First author DOI 10.18632/oncotarget.9402↗
Closest collaborators
The 24 strongest of 24 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Jens Thomas Siveke · 4 shared papers, 2016–2020 · strength 0.27
- Paper Loss of Wasl improves pancreatic cancer outcome. DOI 10.1172/jci.insight.127275↗
- Paper MEK Inhibition Targets Cancer Stem Cells and Impedes Migration of Pancreatic Cancer Cells In Vitro and In Vivo. DOI 10.1155/2019/8475389↗
- Paper Hes1 Controls Exocrine Cell Plasticity and Restricts Development of Pancreatic Ductal Adenocarcinoma in a Mouse Model. DOI 10.1016/j.ajpath.2016.07.025↗
- Roland Michael Schmid · 3 shared papers, 2016–2020 · strength 0.19
- Paper Loss of Wasl improves pancreatic cancer outcome. DOI 10.1172/jci.insight.127275↗
- Paper Hes1 Controls Exocrine Cell Plasticity and Restricts Development of Pancreatic Ductal Adenocarcinoma in a Mouse Model. DOI 10.1016/j.ajpath.2016.07.025↗
- Paper Membranous CD24 drives the epithelial phenotype of pancreatic cancer. DOI 10.18632/oncotarget.9402↗
- Clara Lubeseder–Martellato · 3 shared papers, 2016–2020 · strength 0.19
- Paper Loss of Wasl improves pancreatic cancer outcome. DOI 10.1172/jci.insight.127275↗
- Paper Hes1 Controls Exocrine Cell Plasticity and Restricts Development of Pancreatic Ductal Adenocarcinoma in a Mouse Model. DOI 10.1016/j.ajpath.2016.07.025↗
- Paper Membranous CD24 drives the epithelial phenotype of pancreatic cancer. DOI 10.18632/oncotarget.9402↗
- Guido von Figura · 2 shared papers, 2016–2020 · strength 0.14
- Maximilian Reichert · 2 shared papers, 2016–2020 · strength 0.14
- Marija Trajkovic‐Arsic · 2 shared papers, 2016–2019 · strength 0.13
- Paper MEK Inhibition Targets Cancer Stem Cells and Impedes Migration of Pancreatic Cancer Cells In Vitro and In Vivo. DOI 10.1155/2019/8475389↗
- Paper Hes1 Controls Exocrine Cell Plasticity and Restricts Development of Pancreatic Ductal Adenocarcinoma in a Mouse Model. DOI 10.1016/j.ajpath.2016.07.025↗
- Bence Sipos · 2 shared papers, 2016 · strength 0.10
- Marina Lesina · 1 shared paper, 2020 · strength 0.09
- Zahra Dantes · 1 shared paper, 2020 · strength 0.09
- Henrik Einwächter · 1 shared paper, 2020 · strength 0.09
- Roland Rad · 1 shared paper, 2020 · strength 0.09
- Kanishka Tiwary · 1 shared paper, 2019 · strength 0.08
- Eva Rodríguez-Aznar · 1 shared paper, 2019 · strength 0.08
- Karolin Walter · 1 shared paper, 2019 · strength 0.08
- Jiangning Gu · 1 shared paper, 2019 · strength 0.08
- Patrick Christian Hermann · 1 shared paper, 2019 · strength 0.08
- Johann Gout · 1 shared paper, 2019 · strength 0.08
- Thomas Theodor Werner Seufferlein · 1 shared paper, 2019 · strength 0.08
- Bruno Sáinz · 1 shared paper, 2019 · strength 0.08
- Barbara T. Grünwald · 1 shared paper, 2016 · strength 0.05
- Irina Heid · 1 shared paper, 2016 · strength 0.05
- Günter Schneider · 1 shared paper, 2016 · strength 0.05
- Rickmer Braren · 1 shared paper, 2016 · strength 0.05
- Matthias Wirth · 1 shared paper, 2016 · strength 0.05
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.